Src, a non-receptor tyrosine kinase, contributes to tumorigenesis in various cancer types (Abula et al. 2021) and, more specifically, promotes endocrine resistance in breast cancers (Hiscox et al. 2009; Morgan et al. 2009; Vallabhaneni et al. 2011). Here, NTRK1 is linked to breast carcinoma.